In vitro toxicity assessment of pre- and post-incinerated organomodified nanoclays on airway epithelial and lung fibroblast cells

Use of two-dimensional organomodified nanoclays (ONCs) in nanocomposites continues to grow, however, may pose an inhalation hazard and risk for fixed airway disease which partially relies on epithelial and fibroblast cell responses.